Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TRIHEPTANOIN, with a corresponding US DMF Number 39430.
Remarkably, this DMF maintains an Active status since its submission on February 08, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 21, 2024, and payment made on January 25, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II